SG25195G - Hybrid interferons - Google Patents
Hybrid interferonsInfo
- Publication number
- SG25195G SG25195G SG25195A SG25195A SG25195G SG 25195 G SG25195 G SG 25195G SG 25195 A SG25195 A SG 25195A SG 25195 A SG25195 A SG 25195A SG 25195 G SG25195 G SG 25195G
- Authority
- SG
- Singapore
- Prior art keywords
- interferons
- hybrid interferons
- novel hybrid
- hybrid
- interferon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/142—Interferon
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG25195A SG25195G (en) | 1985-06-11 | 1995-02-16 | Hybrid interferons |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858514722A GB8514722D0 (en) | 1985-06-11 | 1985-06-11 | Hybrid interferon |
GB858514723A GB8514723D0 (en) | 1985-06-11 | 1985-06-11 | Hybrid alpha-interferon |
GB858514726A GB8514726D0 (en) | 1985-06-11 | 1985-06-11 | Hybrid polypeptides |
GB858514724A GB8514724D0 (en) | 1985-06-11 | 1985-06-11 | Hybrid alpha-interferon |
GB858514725A GB8514725D0 (en) | 1985-06-11 | 1985-06-11 | Hybrid polypeptide |
SG25195A SG25195G (en) | 1985-06-11 | 1995-02-16 | Hybrid interferons |
Publications (1)
Publication Number | Publication Date |
---|---|
SG25195G true SG25195G (en) | 1995-08-18 |
Family
ID=27516593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG25195A SG25195G (en) | 1985-06-11 | 1995-02-16 | Hybrid interferons |
Country Status (20)
Country | Link |
---|---|
US (2) | US4885166A (de) |
EP (1) | EP0205404B1 (de) |
JP (2) | JPH0655759B2 (de) |
KR (1) | KR920002267B1 (de) |
AT (1) | ATE78262T1 (de) |
AU (1) | AU598196B2 (de) |
CA (1) | CA1285507C (de) |
CY (1) | CY1842A (de) |
DE (1) | DE3685996T2 (de) |
DK (1) | DK168794B1 (de) |
FI (1) | FI90983C (de) |
GR (1) | GR861497B (de) |
HK (1) | HK99895A (de) |
HU (1) | HU203255B (de) |
IE (1) | IE57865B1 (de) |
IL (1) | IL79085A (de) |
NO (1) | NO175602C (de) |
NZ (1) | NZ216485A (de) |
PT (1) | PT82736B (de) |
SG (1) | SG25195G (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5359035A (en) * | 1985-12-21 | 1994-10-25 | Hoechst Aktiengesellschaft | Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF) |
DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
GB8803365D0 (en) * | 1988-02-13 | 1988-03-16 | Ciba Geigy Ag | Antiviral combination |
EP0331635A3 (de) * | 1988-02-29 | 1990-02-28 | The Board of Regents of the University of Texas System | Zubereitungen zur Behandlung von Blasenkrebs. |
US5273889A (en) * | 1990-08-22 | 1993-12-28 | University Of Saskatchewan | Gamma-iterferon-leukotoxin gene fusions and uses thereof |
US5594107A (en) * | 1990-08-22 | 1997-01-14 | University Of Saskatchewan | Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
JP3149182B2 (ja) * | 1990-08-29 | 2001-03-26 | ジェネティックス・インスティテュート・インコーポレイテッド | 多領域造血刺激因子類 |
US5372808A (en) † | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
DE69222013T2 (de) * | 1991-12-16 | 1998-01-29 | Ciba Geigy Ag | Endoplasmatisches Retikulum-ständige rekombinante dibasische Endoprotease und deren Verwendungen |
US5676942A (en) * | 1992-02-10 | 1997-10-14 | Interferon Sciences, Inc. | Composition containing human alpha interferon species proteins and method for use thereof |
DE69323131T2 (de) * | 1992-03-10 | 1999-09-16 | La Jolla Cancer Research Foundation, La Jolla | Rekombinierte alkalische phosphatase aus kälberdarm |
TW218846B (de) * | 1992-04-07 | 1994-01-11 | Ciba Geigy | |
JPH078215A (ja) * | 1993-04-30 | 1995-01-13 | Kawasaki Steel Corp | ドコサヘキサエン酸含有海洋性微細藻類食品素材およびその製造方法 |
TW249202B (de) * | 1993-08-13 | 1995-06-11 | Ciba Gerigy Corp | |
ATE207538T1 (de) | 1995-02-09 | 2001-11-15 | Behringwerke Ag | Verfahren zur produktion von proteinen |
TW442492B (en) * | 1995-07-26 | 2001-06-23 | Novartis Ag | Process for the enrichment of interferon |
US6685933B1 (en) * | 1998-07-28 | 2004-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Interferon α hybrids |
IL142282A0 (en) | 1998-10-16 | 2002-03-10 | Biogen Inc | Compositions containing polymer conjugates of interferon-beta-1a |
US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
AU2002225870B2 (en) * | 2000-11-03 | 2006-09-21 | Intarcia Therapeutics, Inc. | Method for short-term and long-term drug dosimetry |
US7087726B2 (en) * | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
FR2821625B1 (fr) * | 2001-03-01 | 2003-05-16 | Genodyssee | Nouveaux polynucleotides comportant un polymorphisme de type snp fonctionnel dans la sequence nucleotidique du gene ifn-alpha-2 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques |
FR2823220B1 (fr) * | 2001-04-04 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo) |
KR20040053291A (ko) * | 2001-11-09 | 2004-06-23 | 바이오메디신즈 인코포레이티드 | 오메가 인터페론을 이용한 질환 치료 방법 |
US20040175359A1 (en) * | 2002-11-12 | 2004-09-09 | Desjarlais John Rudolph | Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity |
KR20050086498A (ko) * | 2002-11-18 | 2005-08-30 | 맥시겐, 인크. | 인터페론-알파 폴리펩티드 및 접합체 |
US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
AU2005245918A1 (en) | 2004-05-19 | 2005-12-01 | F. Hoffmann-La Roche Ag | Interferon-alpha polypeptides and conjugates |
JP2008509889A (ja) * | 2004-06-30 | 2008-04-03 | イージェン コーポレーション | ペグ化インターフェロンα−1b |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
BRPI0609809A2 (pt) | 2005-05-18 | 2011-10-11 | Maxygen Inc | polipeptìdeo isolado ou recombinante, conjugado, composição, polinucleotìdeo isolado ou recombinante, célula hospedeira, vetor, métodos para preparar o polipeptìdeo, para preparar um conjugado, para inibir replicação de um vìrus em células infectadas com o vìrus para reduzir o numero de cópias de um vìrus em células infectadas com o vìrus, para reduzir o nìvel de rna de hcv no soro de um paciente infectado com hcv, para reduzir o nìvel de dna de hbv em soro de um paciente infectado com hbv e para reduzir o nìvel de rna de hiv em soro de um paciente infectado com hiv, e, uso do polipeptìdeo ou do conjugado |
CN101453982B (zh) | 2006-05-30 | 2011-05-04 | 精达制药公司 | 两件式内部通道渗透递送系统流动调节器 |
SI2041259T1 (sl) | 2006-07-14 | 2016-04-29 | Dpx Holdings B.V. | Izboljšan postopek kultiviranja celic |
WO2008021133A2 (en) | 2006-08-09 | 2008-02-21 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
AU2007327993B2 (en) | 2006-12-06 | 2013-06-20 | Medimmune, Llc. | Methods of treating systemic lupus erythematosus |
EP2157967B1 (de) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspensionsformulierungen insulinotroper peptide und ihre verwendung |
AU2008247815B2 (en) * | 2007-05-02 | 2012-09-06 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
AU2008247395A1 (en) | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Auto-antibody markers of autoimmune disease |
US7625555B2 (en) | 2007-06-18 | 2009-12-01 | Novagen Holding Corporation | Recombinant human interferon-like proteins |
EP2219452B1 (de) | 2007-11-05 | 2015-10-14 | MedImmune, LLC | Verfahren zur behandlung von skleroderm |
CA2714410A1 (en) | 2008-02-08 | 2009-08-13 | Medimmune, Llc | Disease markers and uses thereof |
EP2240155B1 (de) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe |
MX2012002640A (es) | 2009-09-03 | 2012-06-25 | Medimmune Llc | Diagnostico de interferon tipo 1. |
CN104323981B (zh) | 2009-09-28 | 2019-03-12 | 精达制药公司 | 基本稳态药物递送的快速建立和/或终止 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
EP2686002B1 (de) | 2011-03-15 | 2018-01-24 | Biogen Inc. | Verfahren zur minderung grippeähnlicher symptome mittels intramuskulärer verabreichung von interferon unter verwendung von dosiseskalierung mit schneller titrierung |
US8729236B2 (en) * | 2011-05-23 | 2014-05-20 | Hal S. Padgett | Selection and characterization of novel plant-derived recombinant human interferons with broad spectrum activity |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
WO2016196851A2 (en) | 2015-06-03 | 2016-12-08 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
MX2018014016A (es) | 2016-05-16 | 2019-08-01 | Intarcia Therapeutics Inc | Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos. |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
AU2020222262B2 (en) | 2019-02-15 | 2024-06-20 | Astrazeneca Ab | Type I interferon-mediated disorders |
KR102594862B1 (ko) * | 2023-06-14 | 2023-10-27 | (주) 신성하이스킬 | 화재방지 파쇄 시스템 |
KR102570958B1 (ko) * | 2023-06-14 | 2023-08-25 | (주) 신성하이스킬 | 화재방지 4축 파쇄장치 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO164037C (no) * | 1980-01-08 | 1990-08-22 | Biogen Inc | Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type. |
ES506955A0 (es) * | 1980-11-10 | 1983-02-01 | Genentech Inc | Un procedimiento para producir un polipeptido antiviral. |
US4414150A (en) * | 1980-11-10 | 1983-11-08 | Genentech, Inc. | Hybrid human leukocyte interferons |
US4456748A (en) * | 1981-02-23 | 1984-06-26 | Genentech, Inc. | Hybrid human leukocyte interferons |
GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
IT1167610B (it) * | 1982-01-19 | 1987-05-13 | Cetus Corp | Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione |
GB8315980D0 (en) * | 1983-06-10 | 1983-07-13 | Biogen Nv | Producing hybrid dna sequences |
GB8317880D0 (en) * | 1983-07-01 | 1983-08-03 | Searle & Co | Structure and synthesis of interferons |
EP0146903A3 (de) * | 1983-12-19 | 1987-07-22 | Schering Corporation | Herstellung eines ein Hybrid-Interferon-Spezies kodierenden Vektors |
GB8412564D0 (en) * | 1984-05-17 | 1984-06-20 | Searle & Co | Structure and properties |
EP0173935A1 (de) * | 1984-08-31 | 1986-03-12 | University Patents, Inc. | Hybrid-Lymphoblastoid-Leukozyten-Humaninterferone |
US4716217A (en) * | 1984-08-31 | 1987-12-29 | University Patents, Inc. | Hybrid lymphoblastoid-leukocyte human interferons |
-
1986
- 1986-06-05 DE DE8686810243T patent/DE3685996T2/de not_active Expired - Lifetime
- 1986-06-05 EP EP86810243A patent/EP0205404B1/de not_active Expired - Lifetime
- 1986-06-05 AT AT86810243T patent/ATE78262T1/de not_active IP Right Cessation
- 1986-06-05 US US06/871,059 patent/US4885166A/en not_active Expired - Lifetime
- 1986-06-09 GR GR861497A patent/GR861497B/el unknown
- 1986-06-09 FI FI862461A patent/FI90983C/fi not_active IP Right Cessation
- 1986-06-09 PT PT82736A patent/PT82736B/pt unknown
- 1986-06-09 CA CA000511107A patent/CA1285507C/en not_active Expired - Lifetime
- 1986-06-10 IE IE1542/86A patent/IE57865B1/en not_active IP Right Cessation
- 1986-06-10 HU HU862457A patent/HU203255B/hu unknown
- 1986-06-10 JP JP61132895A patent/JPH0655759B2/ja not_active Expired - Lifetime
- 1986-06-10 KR KR1019860004580A patent/KR920002267B1/ko not_active IP Right Cessation
- 1986-06-10 NZ NZ216485A patent/NZ216485A/en unknown
- 1986-06-10 IL IL79085A patent/IL79085A/xx not_active IP Right Cessation
- 1986-06-10 DK DK272986A patent/DK168794B1/da not_active IP Right Cessation
- 1986-06-10 NO NO862313A patent/NO175602C/no not_active IP Right Cessation
- 1986-06-10 AU AU58499/86A patent/AU598196B2/en not_active Expired
-
1989
- 1989-07-18 US US07/381,444 patent/US5071761A/en not_active Expired - Lifetime
-
1992
- 1992-10-14 JP JP4276015A patent/JPH0736757B2/ja not_active Expired - Lifetime
-
1995
- 1995-02-16 SG SG25195A patent/SG25195G/en unknown
- 1995-06-22 HK HK99895A patent/HK99895A/xx not_active IP Right Cessation
-
1996
- 1996-03-08 CY CY184296A patent/CY1842A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG25195G (en) | Hybrid interferons | |
DE3583521D1 (de) | Antivirale verbindungen. | |
AU2964489A (en) | Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides | |
ES8500996A1 (es) | Meotod de producir un polipeptido. | |
EP0263072A3 (en) | Novel lymphokine related peptides | |
GB2121474B (en) | Two-stage i.c. engine turbocharging | |
IE851906L (en) | Interferons | |
NZ228105A (en) | Antihypertensive hyperimmune milk, its production and medicaments therefrom | |
EP0315637A4 (de) | Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben. | |
AU598460B2 (en) | Process preparing and purifying interferon | |
ES8504795A1 (es) | Un procedimiento para obtener 2,5-anhidro-3,4,6-tri-o-acil-d-alonselenocarboxamida | |
EP0191854A4 (de) | Antivirale peptide. | |
AU4970885A (en) | Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
ES2001108A6 (es) | Un procedimiento para la preparacion de un derivado de gem-dihalo-1,8-diamino -4 -aza-octano. | |
EP0276120A3 (en) | Treatment of certain leukemias with a combination of gamma interferon and alpha interferon | |
ZA877417B (en) | Novel lymphokine related peptides | |
SU939352A1 (ru) | Двухмассный вибрационный конвейер | |
SG134394G (en) | Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same |